Comparison of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridinium (MPP+) effects on mouse heart norepinephrine

This publication has 14 references indexed in Scilit:

• MPP+ (1-methyl-4-phenylpyridine) is a neurotoxin to dopamine-, norepinephrine- and serotonin-containing neurons
  European Journal of Pharmacology, 1987
• Depletion of norepinephrine in mouse heart by 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) mimicked by 1-methyl-4-phenylpyridium (MPP+) and not blocked by deprenyl
  Life Sciences, 1986
• 1-Methyl-4-phenylpyridine is neurotoxic to the nigrostriatal dopamine pathway
  Nature, 1986
• Dopamine but not norepinephrine or serotonin uptake inhibitors protect mice against neurotoxicity of MPTP
  European Journal of Pharmacology, 1985
• Dopaminergic toxicity after the stereotaxic administration of the 1-methyl-4-phenylpyridinium ion (MPP+) to rats
  Neuroscience Letters, 1985
• Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors
  Nature, 1984
• Depletion of cardiac norepinephrine in rats and mice by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
  Biochemical Pharmacology, 1984
• Neurotoxicity of the meperidine analogue N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on brain catecholamine neurons in the mouse
  European Journal of Pharmacology, 1984
• Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
  Science, 1983
• Lowering of epinephrine concentration in rat brain by 2, 3-dichloro-α-methyl-benzylamine, an inhibitor of norepinephrine N-methyltransferase
  Biochemical Pharmacology, 1977